Acacia Pharma announces positive BARHEMSYS ™ rescue treatment data
Acacia Pharma Group plc announces that data and analyses from its positive Phase 3 clinical trial of BARHEMSYS™ (intravenous amisulpride)...
Read More‘Waltzing’ nanoparticles could advance search for better drug delivery methods
Indiana University researchers have discovered that drug-delivering nanoparticles attach to their targets differently based upon their position when they meet....
Read MoreAspirin alone a good clot buster after knee surgery
When it comes to preventing blood clots after a knee replacement, good old aspirin may be just as effective as...
Read MorePIEZO2, a molecular target for treating clinical pain
If you've ever been sunburned, you've experienced the dreaded pain of putting on a shirt the next day. Fabric that...
Read MoreNew pain research centre opens at Royal Holloway, University of London
There is a recognised gap in the study of social aspects of pain, and to truly understand the problem, interdisciplinary...
Read MoreCan stimulating the brain treat chronic pain?
For the first time, researchers at the UNC School of Medicine showed they could target one brain region with a...
Read More5 December 2018, Anaesthesia for the older patient; London
Anaesthesia for the older patient We are all aware of increasing numbers of elderly patients in our hospitals with multiple...
Read MoreSurvey of Post-Operative Prescribing Preferences in the United Kingdom among Anaesthesia professionals*
Emily Pallister produces a survey asking which medications are most widely available to anaesthetists for post-operative prescribing, and if others...
Read More